Dopaminergic dysfunction in unrelated, asymptomatic carriers of a single parkin mutation

被引:105
作者
Khan, NL
Scherfler, C
Graham, E
Bhatia, KP
Quinn, N
Lees, AJ
Brooks, DJ
Wood, NW
Piccini, P
机构
[1] Hammersmith Hosp, Imperial Coll, MRC, Ctr Clin Sci, London W12 0NN, England
[2] Hammersmith Hosp, Imperial Coll, Fac Med, Div Neurosci, London W12 0NN, England
[3] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England
[4] Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England
[5] Royal Free Hosp, Reta Lila Weston Inst Neurol Studies, London NW3 2QG, England
[6] Univ Coll Med Sch, London, England
基金
英国医学研究理事会;
关键词
D O I
10.1212/01.WNL.0000148725.48740.6D
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkin disease is usually autosomal recessive; however, two studies have shown that asymptomatic heterozygotes have nigrostriatal dysfunction and even manifest subtle extrapyramidal signs. The authors used F-18-dopa PET to study 13 asymptomatic parkin heterozygotes and found a significant reduction of F-18-dopa uptake in caudate, putamen, ventral, and dorsal midbrain compared with control subjects. Four had subtle extrapyramidal signs. Parkin heterozygosity is a risk factor for nigrostriatal dysfunction and in some may contribute to late-onset Parkinson disease.
引用
收藏
页码:134 / 136
页数:3
相关论文
共 10 条
[1]   Parkin disease: a phenotypic study of a large case series [J].
Khan, NL ;
Graham, E ;
Critchley, P ;
Schrag, AE ;
Wood, NW ;
Lees, AJ ;
Bhatia, KP ;
Quinn, N .
BRAIN, 2003, 126 :1279-1292
[2]   Progression of nigrostriatal dysfunction in a parkin kindred:: an [18F] dopa PET and clinical study [J].
Khan, NL ;
Brooks, DJ ;
Pavese, N ;
Sweeney, MG ;
Wood, NW ;
Lees, AJ ;
Piccini, P .
BRAIN, 2002, 125 :2248-2256
[3]   Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism:: An 18F-dopa PET study [J].
Khan, NL ;
Valente, EM ;
Bentivoglio, AR ;
Wood, NW ;
Albanese, A ;
Brooks, DJ ;
Piccini, P .
ANNALS OF NEUROLOGY, 2002, 52 (06) :849-853
[4]   Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease [J].
Lücking, CB ;
Chesneau, V ;
Lohmann, E ;
Verpillat, P ;
Dulac, C ;
Bonnet, AM ;
Gasparini, F ;
Agid, Y ;
Dürr, A ;
Brice, A .
ARCHIVES OF NEUROLOGY, 2003, 60 (09) :1253-1256
[5]   Parkin mutations and susceptibility alleles in late-onset Parkinson's disease [J].
Oliveira, SA ;
Scott, WK ;
Martin, ER ;
Nance, MA ;
Watts, RL ;
Hubble, JP ;
Koller, WC ;
Pahwa, R ;
Stern, MB ;
Hiner, BC ;
Ondo, WG ;
Allen, FH ;
Scott, BL ;
Goetz, CG ;
Small, GW ;
Mastaglia, F ;
Stajich, JM ;
Zhang, FY ;
Booze, MW ;
Winn, MP ;
Middleton, LT ;
Haines, JL ;
Pericak-Vance, MA ;
Vance, JM .
ANNALS OF NEUROLOGY, 2003, 53 (05) :624-629
[6]   THE IDENTIFICATION OF PRESYMPTOMATIC PARKINSONISM - CLINICAL AND (F-18) DOPA POSITRON EMISSION TOMOGRAPHY STUDIES IN AN IRISH KINDRED [J].
SAWLE, GV ;
WROE, SJ ;
LEES, AJ ;
BROOKS, DJ ;
FRACKOWIAK, RSJ .
ANNALS OF NEUROLOGY, 1992, 32 (05) :609-617
[7]   Striatal and cortical pre- and postsynaptic dopaminergic dysfunction in sporadic parkin-linked parkinsonism [J].
Scherfler, C ;
Khan, NL ;
Pavese, N ;
Eunson, L ;
Graham, E ;
Lees, AJ ;
Quinn, NP ;
Wood, NW ;
Brooks, DJ ;
Piccini, PP .
BRAIN, 2004, 127 :1332-1342
[8]   Increase in dopamine turnover occurs early in Parkinson's disease:: Evidence from a new modeling approach to PET 18F-fluorodopa data [J].
Sossi, V ;
de la Fuente-Fernández, I ;
Holden, JE ;
Doudet, DJ ;
McKenzie, J ;
Stoessl, AJ ;
Ruth, TJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2002, 22 (02) :232-239
[9]   Functional association of the parkin gene promoter with idiopathic Parkinson's disease [J].
West, AB ;
Maraganore, D ;
Crook, J ;
Lesnick, T ;
Lockhart, PJ ;
Wilkes, KM ;
Kapatos, G ;
Hardy, JA ;
Farrer, MJ .
HUMAN MOLECULAR GENETICS, 2002, 11 (22) :2787-2792
[10]   Plasticity of the nigropallidal pathway in Parkinson's disease [J].
Whone, AL ;
Moore, RY ;
Piccini, PP ;
Brooks, DJ .
ANNALS OF NEUROLOGY, 2003, 53 (02) :206-213